Rapid elimination of protein S-100B from serum after minor head trauma
- PMID: 16503799
- DOI: 10.1089/neu.2006.23.149
Rapid elimination of protein S-100B from serum after minor head trauma
Abstract
Protein S-100B is released into the circulation after traumatic brain injury, and its serum concentration relates to measures of injury severity and outcome. These properties have led to interest in its development as a marker for clinical use, particularly in the prediction of adverse outcome for those with apparently trivial injuries. Before it can be used in populations of patients with head injuries, however, more needs to be understood about its release and elimination. This study was designed to estimate the elimination half-life of S-100B from the circulation after minor head trauma. We studied 14 patients with minor head injuries and measured serum S-100B serially after initial assessment in the Emergency Department of an inner city teaching hospital. We used curve-fit analysis to estimate the elimination constant that best fitted our data, and from this estimated the elimination half-life of protein S-100B. We estimated the mean half-life in this setting to be 97 min (95% confidence interval [CI] of 75-136 min). S-100B is cleared rapidly, relative to the time elapsed between injury and initial assessment in the Emergency Department. Variation in the time elapsed between injury and sampling is likely to influence the accuracy of head injury outcome prediction based on S-100B concentrations in serum, and should be considered when designing future studies.
Similar articles
-
Early S-100B serum level correlates to quality of life in patients after severe head injury.Brain Inj. 2002 Sep;16(9):807-16. doi: 10.1080/02699050210128933. Brain Inj. 2002. PMID: 12217206
-
Protein S-100b serum levels in trauma-induced brain death.Neurology. 2003 Mar 25;60(6):947-51. doi: 10.1212/01.wnl.0000049931.77887.7f. Neurology. 2003. PMID: 12654958
-
Predictive value of S-100B protein and neuron specific-enolase as markers of traumatic brain damage in clinical use.Brain Inj. 2006 May;20(5):463-8. doi: 10.1080/02699050600664418. Brain Inj. 2006. PMID: 16716992
-
Head injury outcome prediction: a role for protein S-100B?Injury. 2006 Dec;37(12):1098-108. doi: 10.1016/j.injury.2006.07.014. Epub 2006 Oct 30. Injury. 2006. PMID: 17070812 Review.
-
Serum S-100B protein as a molecular marker in severe traumatic brain injury.Restor Neurol Neurosci. 2003;21(3-4):159-69. Restor Neurol Neurosci. 2003. PMID: 14530578 Review.
Cited by
-
Serum biomarkers of hypoxic-ischemic brain injury.Physiol Res. 2023 Dec 29;72(S5):S461-S474. doi: 10.33549/physiolres.935214. Physiol Res. 2023. PMID: 38165751 Free PMC article. Review.
-
Utility of S100B Serum Level for the Determination of Concussion in Male Rugby Players.Sports Med. 2017 Apr;47(4):781-789. doi: 10.1007/s40279-016-0579-9. Sports Med. 2017. PMID: 27430504
-
[Serological determination of protein S100B. Significance in emergency diagnosis of adults with mild craniocerebral trauma--meta-analysis].Unfallchirurg. 2012 Oct;115(10):903-12. doi: 10.1007/s00113-010-1946-x. Unfallchirurg. 2012. PMID: 21344309 German.
-
Red blood cell distribution width is associated with neuronal damage in acute ischemic stroke.Aging (Albany NY). 2020 May 23;12(10):9855-9867. doi: 10.18632/aging.103250. Epub 2020 May 23. Aging (Albany NY). 2020. PMID: 32445553 Free PMC article.
-
The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury.Neurosci Biobehav Rev. 2021 Nov;130:433-447. doi: 10.1016/j.neubiorev.2021.08.029. Epub 2021 Aug 30. Neurosci Biobehav Rev. 2021. PMID: 34474049 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous